AbbVie Inc. is 33.0x more valuable than IONIS PHARMACEUTICALS INC by market capitalization ($399.47 B vs $12.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IONS | ABBV |
|---|---|---|
| Market cap | $12.12 B | $399.47 B |
| US-listed rank | #835 | #28 |
| Revenue (latest FY) | $943.71M | $61.16B |
| Net income (latest FY) | -$381.39M | $4.23B |
| Net margin | -40.4% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 2,623 | 1,008 |
AbbVie Inc. is 33.0x more valuable than IONIS PHARMACEUTICALS INC by market capitalization ($399.47 B vs $12.12 B).
In their latest fiscal years, IONIS PHARMACEUTICALS INC reported $943.71M in revenue while AbbVie Inc. reported $61.16B.
Full pages: IONIS PHARMACEUTICALS INC and AbbVie Inc., or browse the full rankings.